One week after treatment, the Tau mice demonstrated similar levels of OR memory and synaptic transmission to control animals, suggesting that ChABC may be effective in restoring memory loss in neurodegenerative disorders such as AD (Yang et al., 2015). Here, MAPT is linked to Alzheimer disease.